PMI raises 2026 diluted EPS forecast for currency only
Group CEO Jacek Olczak presents at Barclays Conference. The adjusted EPS range of $8.35-$8.50 reflects a projected 10.7-12.7% increase over 2025.
See the latest news and media coverage for PMI. We track all announcements, press releases, and industry mentions in real time, all in one place.
Last updated
In short: PMI increased its 2026 profit forecast and received U.S. FDA approval to market ZYN nicotine pouches as modified risk tobacco products.
Group CEO Jacek Olczak presents at Barclays Conference. The adjusted EPS range of $8.35-$8.50 reflects a projected 10.7-12.7% increase over 2025.
The FDA issued Marketing Granted Orders for 11 ZYN ULTRA products to Swedish Match USA, expanding PMI's smoke-free portfolio. Authorization includes 9mg and one 11mg variant following scientific review.
The Colorado facility will produce ZYN nicotine pouches and create 500 jobs, strengthening U.S. manufacturing and export capabilities.
Emmanuel Babeau discussed the company's transformation powered by science and innovation.
Philip Morris International announced today that the U.S. Food and Drug Administration (FDA) has granted tobacco product risk modification orders...
Altria Group, Inc. and Philip Morris ... which Philip Morris USA, an operating subsidiary of Altria, will produce traditional combustible cigarettes for PMI’s non-U.S. affiliates...
Detailed price information for Philip Morris International (PM-N) from The Globe and Mail including charting and trades.
Philip Morris International Inc (NYSE: PM) announced that the US Food and Drug Administration (FDA) has issued Marketing Granted Orders to its US affiliate, Swedish...
Track PMI and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to PMI and other trending companies.